Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2017
The 7th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland
Presentation Date(s):- May 5 – 8, 2017
- Total Presentations: 359
-
+
Management of brain metastases
- Type: Educational session
- Presentations: 5
- Moderators:S. Ekman
- Coordinates: 5/05/2017, 14:30 - 16:00, Room B
-
+
Systemic treatment of brain metastases
14:50 - 15:10 | Author(s): J.C. Yang
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Poster Display Session
- Type: Poster Display Session
- Presentations: 142
- Coordinates: 5/07/2017, 12:30 - 13:00, Hall 1
-
+
100P - Afatinib vs gefitinib for treatment-naïve patients with EGFRm+ NSCLC (LUX-Lung 7): Analysis of time to treatment failure and impact of afatinib dose adjustment
12:30 - 12:30 | Author(s): J.C. Yang
- Abstract
Loading... -
+
102P - LUX-Lung 8 phase III trial: Analysis of long-term response to second-line afatinib in patients with advanced squamous cell carcinoma (SCC) of the lung
12:30 - 12:30 | Author(s): J.C. Yang
- Abstract
Loading...
-
+
Targeted therapies and immunotherapies
- Type: Poster Discussion session
- Presentations: 10
- Moderators:S. Ekman
- Coordinates: 5/07/2017, 14:45 - 15:45, Room W
-
+
92PD - First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders (LTRs) in the LUX-Lung (LL) 3, 6 and 7 trials
15:15 - 15:15 | Author(s): M. Schuler
- Abstract
Loading... -
+
93PD - Afatinib (A) vs gefitinib (G) in patients with EGFR mutation-positive (EGFRm+) NSCLC: Updated OS data from the phase IIb trial LUX-Lung 7 (LL7)
15:15 - 15:15 | Author(s): J. Corral
- Abstract
Loading...